UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Multicenter Evaluation of the Clinical Outcomes of Daptomycin with and without Concomitant β-Lactams in Patients with Staphylococcus aureus Bacteremia and Mild to Moderate Renal Impairment

Antimicrobial Agents and Chemotherapy, 2013-03, Vol.57 (3), p.1192-1200

2013

Volltextzugriff (PDF)

Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy

The Annals of pharmacotherapy, 2009-07, Vol.43 (7), p.1211

2009

Volltextzugriff (PDF)

Daptomycin in the Treatment of Patients with Infective Endocarditis: Experience from a Registry

The American journal of medicine, 2007-10, Vol.120 (10), p.S28-S33

2007

Volltextzugriff (PDF)

Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia

Clinical therapeutics, 2015-07, Vol.37 (7), p.1443-1453.e2

2015

Volltextzugriff (PDF)

Clinical Experience with Daptomycin for the Treatment of Patients with Osteomyelitis

The American journal of medicine, 2007-10, Vol.120 (10), p.S13-S20

2007

Volltextzugriff (PDF)

Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: A retrospective cohort study utilizing the Cubicin® Outcomes Registry and Experience

Clinical therapeutics, 2009-09, Vol.31 (9), p.1936-1945

2009

Volltextzugriff (PDF)

Cubicin Outcomes Registry and Experience (CORE) Methodology

The American journal of medicine, 2007-10, Vol.120 (10), p.S4-S5

2007

Volltextzugriff (PDF)

Postmarketing Clinical Experience in Patients with Skin and Skin-Structure Infections Treated with Daptomycin

The American journal of medicine, 2007-10, Vol.120 (10), p.S6-S12

2007

Volltextzugriff (PDF)

Daptomycin in the Treatment of Bacteremia

The American journal of medicine, 2007-10, Vol.120 (10), p.S21-S27

2007

Volltextzugriff (PDF)

Daptomycin for the treatment of surgical site infections

Surgery, 2009-08, Vol.146 (2), p.316-324

2009

Volltextzugriff (PDF)

Assessing Appropriateness of Antimicrobial Therapy: In the Eye of the Interpreter

Clinical infectious diseases, 2014-10, Vol.59 (suppl_3), p.S154-S161

2014

Volltextzugriff (PDF)

Daptomycin Experience in Patients with Human Immunodeficiency Virus and Resistant Gram-Positive Infections

Journal of the International Association of Providers of AIDS Care, 2015-05, Vol.14 (3), p.202-206

2015

Volltextzugriff (PDF)

Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin® Outcomes Registry and Experience (CORE)

International journal of antimicrobial agents, 2009-06, Vol.33 (6), p.543-548

2009

Volltextzugriff (PDF)

Daptomycin use in neutropenic patients with documented gram-positive infections

Supportive care in cancer, 2014, Vol.22 (1), p.7-14

2014

Volltextzugriff (PDF)

Outcomes and Metrics for Antimicrobial Stewardship: Survey of Physicians and Pharmacists

Clinical infectious diseases, 2014-10, Vol.59 (suppl_3), p.S108-S111

2014

Volltextzugriff (PDF)

Safety of daptomycin in patients completing more than 14 days of therapy: results from the Cubicin® Outcomes Registry and Experience

International journal of antimicrobial agents, 2013-05, Vol.41 (5), p.421-425

2013

Volltextzugriff (PDF)

Duration of prior vancomycin therapy and subsequent daptomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia

Diagnostic microbiology and infectious disease, 2015-10, Vol.83 (2), p.193-197

2015

Volltextzugriff (PDF)

A retrospective study of outcomes of device-associated osteomyelitis treated with daptomycin

BMC infectious diseases, 2016-06, Vol.16 (1), p.310-310, Article 310

2016

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials

Clinical pharmacokinetics, 1999-05, Vol.36 (5), p.353-373

1999

Volltextzugriff (PDF)

Daptomycin: a comparison of two intravenous formulations

Drug design, development and therapy, 2018-01, Vol.12, p.1953-1958

2018

Volltextzugriff (PDF)

Safety and clinical outcomes among older adults receiving daptomycin therapy: Insights from a patient registry

The American journal of geriatric pharmacotherapy, 2010-12, Vol.8 (6), p.551-561

2010

Volltextzugriff (PDF)

Breaking Down the Barriers: Challenges With Development and Implementation of an Industry-Sponsored Antimicrobial Stewardship Data Collection and Analysis Tool

Clinical infectious diseases, 2014-10, Vol.59 (suppl_3), p.S179-S184

2014

Volltextzugriff (PDF)

Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs

Journal of antimicrobial chemotherapy, 2010-08, Vol.65 (8), p.1784-1791

2010

Volltextzugriff (PDF)

Safety of Daptomycin in Patients Receiving Hemodialysis

Pharmacotherapy, 2011-07, Vol.31 (7), p.665-672

2011

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Englisch
(65)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(44)
Science & Technology
(44)
Life Sciences & Biomedicine
(43)
Female
(34)
Male
(33)
Aged
(29)
Anti-Bacterial Agents - Therapeutic Use
(26)
Biological And Medical Sciences
(26)
Medical Sciences
(26)
Middle Aged
(26)
Daptomycin - Therapeutic Use
(25)
Pharmacology & Pharmacy
(24)
Adult
(23)
Daptomycin
(23)
Pharmacology. Drug Treatments
(21)
Retrospective Studies
(18)
Treatment Outcome
(18)
Infectious Diseases
(16)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(13)
Daptomycin - Adverse Effects
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multicenter Evaluation of the Clinical Outcomes of Daptomycin with and without Concomitant β-Lactams in Patients with Staphylococcus aureus Bacteremia and Mild to Moderate Renal Impairment

Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy

Daptomycin in the Treatment of Patients with Infective Endocarditis: Experience from a Registry

Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation

Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia

Clinical Experience with Daptomycin for the Treatment of Patients with Osteomyelitis

Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: A retrospective cohort study utilizing the Cubicin® Outcomes Registry and Experience

Cubicin Outcomes Registry and Experience (CORE) Methodology

Postmarketing Clinical Experience in Patients with Skin and Skin-Structure Infections Treated with Daptomycin

Daptomycin in the Treatment of Bacteremia

Daptomycin for the treatment of surgical site infections

Assessing Appropriateness of Antimicrobial Therapy: In the Eye of the Interpreter

Daptomycin Experience in Patients with Human Immunodeficiency Virus and Resistant Gram-Positive Infections

Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin® Outcomes Registry and Experience (CORE)

Daptomycin use in neutropenic patients with documented gram-positive infections

Outcomes and Metrics for Antimicrobial Stewardship: Survey of Physicians and Pharmacists

Safety of daptomycin in patients completing more than 14 days of therapy: results from the Cubicin® Outcomes Registry and Experience

Duration of prior vancomycin therapy and subsequent daptomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia

A retrospective study of outcomes of device-associated osteomyelitis treated with daptomycin

Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials

Daptomycin: a comparison of two intravenous formulations

Safety and clinical outcomes among older adults receiving daptomycin therapy: Insights from a patient registry

Breaking Down the Barriers: Challenges With Development and Implementation of an Industry-Sponsored Antimicrobial Stewardship Data Collection and Analysis Tool

Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs

Safety of Daptomycin in Patients Receiving Hemodialysis

Suchergebnisse filtern